Cite

HARVARD Citation

    Lap, C. et al. (2021). Combined Ruxolitinib and Venetoclax Treatment in a Patient with a BCR-JAK2 Rearranged Myeloid Neoplasm. Case reports in neurological medicine. p. . [Online]. 
  
Back to record